HBK Sorce Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,862
| Closed | -$208K | – | 603 |
|
|
2021
Q3 | $208K | Buy |
1,862
+45
| +2% | +$5.03K | 0.01% | 547 |
|
|
2021
Q2 | $294K | Buy |
1,817
+140
| +8% | +$22.7K | 0.02% | 449 |
|
|
2021
Q1 | $204K | Buy |
+1,677
| New | +$204K | 0.01% | 509 |
|
|
2019
Q2 | – | Sell |
-6,530
| Closed | -$233K | – | 417 |
|
|
2019
Q1 | $233K | Buy |
+6,530
| New | +$233K | 0.02% | 378 |
|
|
2018
Q4 | – | Sell |
-6,569
| Closed | -$291K | – | 391 |
|
|
2018
Q3 | $291K | Sell |
6,569
-760
| -10% | -$33.7K | 0.03% | 302 |
|
|
2018
Q2 | $431K | Buy |
7,329
+2,418
| +49% | +$142K | 0.05% | 248 |
|
|
2018
Q1 | $224K | Buy |
+4,911
| New | +$224K | 0.03% | 334 |
|